Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123656312 | 12365631 | 2 | F | 201601 | 20160627 | 20160513 | 20160701 | EXP | US-GLAXOSMITHKLINE-US2016GSK064773 | GLAXOSMITHKLINE | 65.18 | YR | F | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123656312 | 12365631 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
123656312 | 12365631 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 500/50 MCG | 6ZP4084 | 21077 | INHALATION POWDER | |||||||||
123656312 | 12365631 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | LU2Y | 0 | |||||||||
123656312 | 12365631 | 4 | SS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | UNK | U | 5ZP1659 | 0 | CAPSULE | ||||||||
123656312 | 12365631 | 5 | C | LORATIDINE | LORATADINE | 1 | U | 0 | |||||||||||
123656312 | 12365631 | 6 | C | ALBUTEROL + IPRATROPIUM | 2 | U | 0 | ||||||||||||
123656312 | 12365631 | 7 | C | NASONEX | MOMETASONE FUROATE | 1 | U | 0 | |||||||||||
123656312 | 12365631 | 8 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
123656312 | 12365631 | 9 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
123656312 | 12365631 | 10 | C | OXYGEN. | OXYGEN | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123656312 | 12365631 | 1 | Chronic obstructive pulmonary disease |
123656312 | 12365631 | 3 | Chronic obstructive pulmonary disease |
123656312 | 12365631 | 4 | Blood cholesterol abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123656312 | 12365631 | HO |
123656312 | 12365631 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123656312 | 12365631 | Cough | |
123656312 | 12365631 | Dyspnoea | |
123656312 | 12365631 | Emergency care examination | |
123656312 | 12365631 | Increased upper airway secretion | |
123656312 | 12365631 | Nasopharyngitis | |
123656312 | 12365631 | Oxygen saturation decreased | |
123656312 | 12365631 | Pneumonia | |
123656312 | 12365631 | Productive cough | |
123656312 | 12365631 | Rhinovirus infection | |
123656312 | 12365631 | Sinus congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123656312 | 12365631 | 2 | 201602 | 0 | ||
123656312 | 12365631 | 3 | 20130621 | 0 | ||
123656312 | 12365631 | 4 | 201009 | 0 |